When.com Web Search

  1. Ads

    related to: mrna stock price forecast prediction

Search results

  1. Results From The WOW.Com Content Network
  2. Down 79%, Is Moderna Stock a Bad-News Buy on the Dip? - AOL

    www.aol.com/finance/down-79-moderna-stock-bad...

    There was good news to share, but the market focused on a declining sales forecast and hammered the stock lower. Last November, Moderna said it expected 2024 revenue to land in a range between $3 ...

  3. Moderna Faces Analyst Downgrades Amid Revised R&D ... - AOL

    www.aol.com/finance/moderna-faces-analyst...

    Since cutting its 2024 revenue forecast during its second-quarter earnings 2024 call, ... Price Action: MRNA stock closed lower by 2.01% to $68.28 on Friday. ... (MRNA): Free Stock Analysis Report.

  4. After Moderna's Shocking News, Is the Stock a Buy or a Sell?

    www.aol.com/finance/modernas-shocking-news-stock...

    Moderna now forecasts 10 approvals over the coming three years. This is after -- just last year -- forecasting the launch of as many as 15 new products over the next five years.

  5. Is Moderna’s Stock Fully Valued at Current Levels? Analyst ...

    www.aol.com/news/moderna-stock-fully-valued...

    Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results, many would say justifiably so.The biggest question for investors, then, is whether ...

  6. Moderna’s (NASDAQ:MRNA) Valuation Doesn’t match Current Forecasts

    www.aol.com/news/moderna-nasdaq-mrna-valuation...

    After Moderna’s share price gained more than 20% on Friday we decided to investigate the opportunity the share may offer. ... MRNA), Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX). After Moderna ...

  7. Moderna’s Outlook Is Directly Tied to the Eventual Receding ...

    www.aol.com/news/moderna-outlook-directly-tied...

    Covid-19 vaccine giant Moderna (NASDAQ:MRNA) has been on a tear since the second quarter of 2020. It has grown its top line by over 6,500% on a year-over-year basis due to rampant sales of its ...